For research teamsHelp me find a study
Back to all studies
CompletedNCT02618434

Molindone Hydrochloride Extended-Release for ADHD

This study is completed in the United States. It is testing Molindone Hydrochloride Extended-Release for ADHD.

ADHDDrugFrom 6 Years to 12 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Molindone Hydrochloride Extended-Release may be useful for children experiencing ADHD.

What would participation involve?

Participants may receive Molindone Hydrochloride Extended-Release, complete questionnaires or follow-up assessments, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for children with ADHD. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: February 16, 2016
Recruitment status
Completed
Enrollment listed in the registry
297
Sponsor
Supernus Pharmaceuticals, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT02618434
Official title
Assessment of the Efficacy and Safety of Molindone Hydrochloride Extended-Release for the Treatment of Impulsive Aggression in Pediatric Patients With Attention Deficit/Hyperactivity Disorder in Conjunction With Standard ADHD Treatment

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02618434. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 32 sites
  • Metropolitan Neuro Behavioral Institute
    Chandler, Arizona
    Site status: Not listed — confirm with the team
  • Woodland International Research Group
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Sun Valley Research Center
    Imperial, California
    Site status: Not listed — confirm with the team
  • Alliance for Wellness dba Alliance for Research
    Long Beach, California
    Site status: Not listed — confirm with the team
  • ASCLEPES Research Center
    Panorama City, California
    Site status: Not listed — confirm with the team
  • MCB Clinical Research Centers, LLC
    Colorado Springs, Colorado
    Site status: Not listed — confirm with the team
  • Children's National Medical Center/Children's Research Institute
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Gulfcoast Clinical Research Center
    Fort Myers, Florida
    Site status: Not listed — confirm with the team
  • Indago Research & Health Center, Inc.
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • Innovative Clinical Research, Inc
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Laszlo J. Mate, M.D., P.A.
    North Palm Beach, Florida
    Site status: Not listed — confirm with the team
  • APG Research, LLC
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Miami Research Associates
    South Miami, Florida
    Site status: Not listed — confirm with the team
  • University of South Florida- Dept. of Psychiatry and Neurosciences
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Atlanta
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Advanced Clinical Research
    Meridian, Idaho
    Site status: Not listed — confirm with the team
  • AMR Conventions Research
    Naperville, Illinois
    Site status: Not listed — confirm with the team
  • Pedia Research
    Evansville, Indiana
    Site status: Not listed — confirm with the team
  • Pedia Research
    Owensboro, Kentucky
    Site status: Not listed — confirm with the team
  • Louisiana State University Health Sciences Center
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • St. Charles Psychiatric Associates Midwest Research Center
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Alivation Research, LLC
    Lincoln, Nebraska
    Site status: Not listed — confirm with the team
  • Quality Clinical Research
    Omaha, Nebraska
    Site status: Not listed — confirm with the team
  • Hassmann Research Institute
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • Icahn School of Medicine at Mount Sinai
    New York, New York
    Site status: Not listed — confirm with the team
  • University of Cincinnati Department of Psychiatry and Behavioral Neuroscience
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • BioBehavioral Research of Austin P.C.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • InSite Clinical Research
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Houston Clinical Trials
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Ericksen Research & Development
    Clinton, Utah
    Site status: Not listed — confirm with the team
  • Pacific Institute of Medical Sciences
    Bothell, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving SPN-810 (18 mg), SPN-810 (36 mg), Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with adhd; age range: From 6 Years to 12 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Supernus Pharmaceuticals, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.supernus.com. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.